Pancreatic cancer is one of the most aggressive malignant tumours and is associated with the activation of various oncogenes such as Ki-ras and the inactivation of tumour suppressor genes, for example, p16 and p53 (Korc, 1998). This evidence concerns the gene CDKN2A and cancer.